BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:23 PM
 | 
Sep 18, 2008
 |  BC Extra  |  Company News

Actemra gets complete response letter

Roche (SWX:ROG) said that FDA issued a complete response letter for a BLA for Actemra tocilizumab to treat moderate to severe rheumatoid arthritis (RA) in adults. The company...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >